News
Genmab expands its pipeline with $630m Scancell deal
Genmab has licensed another anti-glycan antibody for cancer from UK biotech Scancell as it continues to expand its in-house pipeline.
News
Zepbound tops Wegovy in first head-to-head weight-loss trial
Eli Lilly is playing catch-up to Novo Nordisk in the fast-growing obesity therapy sector but has new data that could tip the balance in its favour.
R&D
Brain-computer interfaces could redefine precision medicine
BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions.
R&D
Partner Content
Biotech Showcase marking 17 years of innovation and opportun...
Biotech Showcase is a cornerstone of the life science industry, with a 17-year history of connecting private and micro- to mid-cap biotech companies with top-tier investors and biopharmaceu
News
MHRA's stature undermined by lack of resources says pharma
The MHRA isn't sufficiently funded to meet its obligations and that could threaten UK investment in life sciences, according to an ABPI report.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
